Medicament for treating pain of breasts

Abstract

The invention discloses a medicament for treating breast pain which is prepared from the following raw materials: malt, tangerine seed, lychee seed, Bupleurum root, Chinese angelica root, root of herbaceous peony, poria cocos, white atractylodes rhizome, radix paeoniae rubrathe, root of red rooted saliva, haw, white mustard seed, and licorice root. The invention realizes quick effect, short course of treatment, low recurrence rate, and no toxic and side actions.

Description

technical field [0001] The invention relates to a medicine for treating breast diseases, in particular to a medicine for treating mastalgia. Background technique [0002] Mastalgia is a common and frequently-occurring disease in women. It is more common in women of childbearing age. It is mainly manifested as flaky thickening of local breast tissue. It often occurs symmetrically in both breasts, especially in the upper outer quadrant of the breasts. Pain It is diffuse dull pain or localized stabbing pain, which changes periodically with menstrual cycle. The disease accounts for about 40% of breast diseases. The clinical manifestations of young women are lumps or pain in one or both breasts, which change with the menstrual cycle, accompanied by premenstrual upset and irritability, chest tightness, belching, and distending pain in both sides. The clinical manifestations of middle-aged married women are mostly breast lumps, The pain changes with the menstrual cycle, often acc...

AI Technical Summary

Problems solved by technology

Due to the complicated pathogenesis of the disease, western medicine believes that the disease is related to endocrine disorders, while traditional Chinese medicine believes that various pathogenic factors cause dysfunction of the breast-related meridians, qi and blood, and viscera. In many clinical manifestations, it is only breast pain. For organic diseases, the examination and treatment of this disease are difficult. Although there are a variety of finished medicines for the treatment of mastalgia in China, they are not highly targeted, have a low cure rate, a long course of treatment, and a high recurrence rate.